vs
Mechanics Bancorp(MCHB)与Royalty Pharma plc(RPRX)财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Mechanics Bancorp的1.4倍($622.0M vs $458.8M),过去两年Mechanics Bancorp的营收复合增速更高(232.1% vs 4.6%)
Mechanics Bancorp是总部位于美国的银行控股公司,核心子公司为Mechanics Bank,提供零售银行、商业银行及财富管理类服务,覆盖储蓄账户、各类贷款、投资咨询等业务,主要服务加利福尼亚州的个人消费者及中小型企业客户。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MCHB vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$458.8M
两年增速更快
MCHB
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $458.8M | $622.0M |
| 净利润 | — | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | — | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益(稀释后) | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MCHB
RPRX
| Q4 25 | $458.8M | $622.0M | ||
| Q3 25 | $255.4M | $609.3M | ||
| Q2 25 | $49.0M | $578.7M | ||
| Q1 25 | $45.4M | $568.2M | ||
| Q4 24 | $29.6M | $593.6M | ||
| Q3 24 | $147.9M | $564.7M | ||
| Q2 24 | $42.9M | $537.3M | ||
| Q1 24 | $41.6M | $568.0M |
净利润
MCHB
RPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $55.2M | $288.2M | ||
| Q2 25 | $-4.4M | $30.2M | ||
| Q1 25 | $-4.5M | $238.3M | ||
| Q4 24 | $-123.3M | $208.2M | ||
| Q3 24 | $39.9M | $544.0M | ||
| Q2 24 | $-6.2M | $102.0M | ||
| Q1 24 | $-7.5M | $4.8M |
营业利润率
MCHB
RPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 17.7% | 70.1% | ||
| Q2 25 | -9.8% | 36.3% | ||
| Q1 25 | -10.5% | 94.0% | ||
| Q4 24 | -312.2% | 60.9% | ||
| Q3 24 | 37.5% | — | ||
| Q2 24 | -18.6% | 50.2% | ||
| Q1 24 | -25.4% | -13.0% |
净利率
MCHB
RPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 21.6% | 47.3% | ||
| Q2 25 | -9.0% | 5.2% | ||
| Q1 25 | -9.8% | 41.9% | ||
| Q4 24 | -416.4% | 35.1% | ||
| Q3 24 | 27.0% | 96.3% | ||
| Q2 24 | -14.5% | 19.0% | ||
| Q1 24 | -18.0% | 0.8% |
每股收益(稀释后)
MCHB
RPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.26 | $0.67 | ||
| Q2 25 | $-0.23 | $0.07 | ||
| Q1 25 | $-0.24 | $0.55 | ||
| Q4 24 | $-6.53 | $0.46 | ||
| Q3 24 | $0.20 | $1.21 | ||
| Q2 24 | $-0.33 | $0.23 | ||
| Q1 24 | $-0.40 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $618.7M |
| 总债务越低越好 | $192.0M | $9.0B |
| 股东权益账面价值 | $2.9B | $9.7B |
| 总资产 | $22.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.92× |
8季度趋势,按日历期对齐
现金及短期投资
MCHB
RPRX
| Q4 25 | $1.0B | $618.7M | ||
| Q3 25 | $1.4B | $938.9M | ||
| Q2 25 | $201.1M | $631.9M | ||
| Q1 25 | $252.2M | $1.1B | ||
| Q4 24 | $999.7M | $929.0M | ||
| Q3 24 | $205.9M | $950.1M | ||
| Q2 24 | $218.7M | $1.8B | ||
| Q1 24 | $320.3M | $843.0M |
总债务
MCHB
RPRX
| Q4 25 | $192.0M | $9.0B | ||
| Q3 25 | $190.1M | $8.9B | ||
| Q2 25 | $225.3M | $8.0B | ||
| Q1 25 | $225.2M | $7.6B | ||
| Q4 24 | $0 | $7.6B | ||
| Q3 24 | $0 | $7.6B | ||
| Q2 24 | $224.9M | $7.6B | ||
| Q1 24 | $224.9M | $6.1B |
股东权益
MCHB
RPRX
| Q4 25 | $2.9B | $9.7B | ||
| Q3 25 | $2.8B | $9.6B | ||
| Q2 25 | $2.4B | $9.5B | ||
| Q1 25 | $400.8M | $9.8B | ||
| Q4 24 | $2.3B | $10.3B | ||
| Q3 24 | $2.3B | $10.3B | ||
| Q2 24 | $2.2B | $9.8B | ||
| Q1 24 | $527.3M | $9.9B |
总资产
MCHB
RPRX
| Q4 25 | $22.4B | $19.6B | ||
| Q3 25 | $22.7B | $19.3B | ||
| Q2 25 | $7.6B | $18.3B | ||
| Q1 25 | $7.8B | $17.6B | ||
| Q4 24 | $16.5B | $18.2B | ||
| Q3 24 | $9.2B | $18.0B | ||
| Q2 24 | $9.3B | $17.7B | ||
| Q1 24 | $9.5B | $16.1B |
负债/权益比
MCHB
RPRX
| Q4 25 | 0.07× | 0.92× | ||
| Q3 25 | 0.07× | 0.93× | ||
| Q2 25 | 0.09× | 0.84× | ||
| Q1 25 | 0.56× | 0.78× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.00× | 0.74× | ||
| Q2 24 | 0.10× | 0.78× | ||
| Q1 24 | 0.43× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $193.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $187.1M | — |
| 自由现金流率自由现金流/营收 | 40.8% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $263.7M | — |
8季度趋势,按日历期对齐
经营现金流
MCHB
RPRX
| Q4 25 | $193.6M | $827.1M | ||
| Q3 25 | $112.0M | $702.6M | ||
| Q2 25 | $-9.8M | $364.0M | ||
| Q1 25 | $-22.5M | $596.1M | ||
| Q4 24 | $292.3M | $742.5M | ||
| Q3 24 | $247.0M | $703.6M | ||
| Q2 24 | $-21.8M | $658.2M | ||
| Q1 24 | $-7.8M | $664.6M |
自由现金流
MCHB
RPRX
| Q4 25 | $187.1M | — | ||
| Q3 25 | $109.1M | — | ||
| Q2 25 | $-9.9M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $285.9M | — | ||
| Q3 24 | $244.5M | — | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-13.9M | — |
自由现金流率
MCHB
RPRX
| Q4 25 | 40.8% | — | ||
| Q3 25 | 42.7% | — | ||
| Q2 25 | -20.2% | — | ||
| Q1 25 | -49.7% | — | ||
| Q4 24 | 965.3% | — | ||
| Q3 24 | 165.4% | — | ||
| Q2 24 | -51.3% | — | ||
| Q1 24 | -33.4% | — |
资本支出强度
MCHB
RPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 14.6% | — |
现金转化率
MCHB
RPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.03× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 6.18× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCHB
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |